Health Care · Medical Devices

TransMedics Group, Inc. TMDX

$76.13-1.87 (-2.40%)delayed quote · as of 2026-07-30 23:56 UTC

Open TMDX in the workspaceCharts, statements, and the evidence behind every figure — free to start.

Market cap

$2.6B

Previous close

$78.00

Volume

870K

52-week range

$60.11 – $156.00

Verdictconfidence 65% · moderate

Solid footing across most dimensions.

3 of 5 dimensions score well. Value and Momentum not scored — not enough data.

Value—2/2 checks

Growth804/5 checks

Quality804/5 checks

Health1003/3 checks

Momentum—0/2 checks

Every check behind these scores — with its numbers, source, and evidence link — is in the workspace. Free account required.

Key ratioslatest filing FY 2025

Value

P/E TTM

17.4

P/E FWD

26.6

EV/EBITDA TTM

16.9

PEG

—

FCF yield TTM

5.8%

Growth

Revenue 3y

+86.4%/yr

Revenue YoY

+37.1%

Expected EPS

−34.5%

Quality

Piotroski F

7 / 9

ROIC

-2086.1%

Gross margin

59.9%

Health

Altman Z

3.81

Current ratio

7.14

Debt/equity

0.02

Momentum

vs 50-day

—

vs 200-day

—

52-wk range

17%

FY 2025: revenue $605.5M · net income $190.3M · free cash flow $133.6M (SEC EDGAR filings)

ALAN GLOBAL INTELLIGENCE · alanglobalintelligence.comquote as of 2026-07-30 23:56 UTC · fundamentals FY 2025 · SEC EDGAR

Verdict

Reading TMDX’s filed statements…

Continue with TMDX in ALAN

Full evidence trail, financial statements back a decade, valuation history, charts, and alerts.

Open in the workspace Create free account

For information and research only. Not investment advice. ALAN does not place trades or execute orders. Figures come from the sources shown and can lag the market; verify independently before making decisions. Past performance is not predictive of future results.